Botulinum Neurotoxins-Global Market Status and Trend Report 2013-2023
Report Summary
Botulinum Neurotoxins-Global Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Botulinum Neurotoxins industry, standing on the readers’ perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Worldwide and Regional Market Size of Botulinum Neurotoxins 2013-2017, and development forecast 2018-2023
Main manufacturers/suppliers of Botulinum Neurotoxins worldwide, with company and product introduction, position in the Botulinum Neurotoxins market
Market status and development trend of Botulinum Neurotoxins by types and applications
Cost and profit status of Botulinum Neurotoxins, and marketing status
Market growth drivers and challenges
The report segments the global Botulinum Neurotoxins market as:
Global Botulinum Neurotoxins Market: Regional Segment Analysis (Regional Production Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
North America
Europe
China
Japan
Rest APAC
Latin America
Global Botulinum Neurotoxins Market: Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Botulinum Neurotoxins A (BoNT/A)
Botulinum Neurotoxins B (BoNT/B)
Botulinum Neurotoxins E (BoNT/E)
Botulinum Neurotoxins F (BoNT/F)
Botulinum Neurotoxins C (BoNT/C)
Botulinum Neurotoxins D (BoNT/D)
Botulinum Neurotoxins G (BoNT/G)
Global Botulinum Neurotoxins Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Medical Uses
Cosmetics
Global Botulinum Neurotoxins Market: Manufacturers Segment Analysis (Company and Product introduction, Botulinum Neurotoxins Sales Volume, Revenue, Price and Gross Margin):
Johnson & Johnson
GSK
Allergan
Chong Kun Dang
Eisai
Nestle
Galderma
Ipsen
Hugel
Mentor
CROMA
Alphaeon
OBI Pharma
Revance Therapeutics
Daewoong Pharmaceutical
Medy-Tox
EpiVax
Anterios
Escape Therapeutics
Lipella
Malvern Cosmeceutics
PharmaVital
Merz Pharma
Transdermal
Valeant Pharmaceuticals
CNBG
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
Botulinum Neurotoxins-Global Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Botulinum Neurotoxins industry, standing on the readers’ perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Worldwide and Regional Market Size of Botulinum Neurotoxins 2013-2017, and development forecast 2018-2023
Main manufacturers/suppliers of Botulinum Neurotoxins worldwide, with company and product introduction, position in the Botulinum Neurotoxins market
Market status and development trend of Botulinum Neurotoxins by types and applications
Cost and profit status of Botulinum Neurotoxins, and marketing status
Market growth drivers and challenges
The report segments the global Botulinum Neurotoxins market as:
Global Botulinum Neurotoxins Market: Regional Segment Analysis (Regional Production Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
North America
Europe
China
Japan
Rest APAC
Latin America
Global Botulinum Neurotoxins Market: Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Botulinum Neurotoxins A (BoNT/A)
Botulinum Neurotoxins B (BoNT/B)
Botulinum Neurotoxins E (BoNT/E)
Botulinum Neurotoxins F (BoNT/F)
Botulinum Neurotoxins C (BoNT/C)
Botulinum Neurotoxins D (BoNT/D)
Botulinum Neurotoxins G (BoNT/G)
Global Botulinum Neurotoxins Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Medical Uses
Cosmetics
Global Botulinum Neurotoxins Market: Manufacturers Segment Analysis (Company and Product introduction, Botulinum Neurotoxins Sales Volume, Revenue, Price and Gross Margin):
Johnson & Johnson
GSK
Allergan
Chong Kun Dang
Eisai
Nestle
Galderma
Ipsen
Hugel
Mentor
CROMA
Alphaeon
OBI Pharma
Revance Therapeutics
Daewoong Pharmaceutical
Medy-Tox
EpiVax
Anterios
Escape Therapeutics
Lipella
Malvern Cosmeceutics
PharmaVital
Merz Pharma
Transdermal
Valeant Pharmaceuticals
CNBG
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
CHAPTER 1 OVERVIEW OF BOTULINUM NEUROTOXINS
1.1 Definition of Botulinum Neurotoxins in This Report
1.2 Commercial Types of Botulinum Neurotoxins
1.2.1 Botulinum Neurotoxins A (BoNT/A)
1.2.2 Botulinum Neurotoxins B (BoNT/B)
1.2.3 Botulinum Neurotoxins E (BoNT/E)
1.2.4 Botulinum Neurotoxins F (BoNT/F)
1.2.5 Botulinum Neurotoxins C (BoNT/C)
1.2.6 Botulinum Neurotoxins D (BoNT/D)
1.2.7 Botulinum Neurotoxins G (BoNT/G)
1.3 Downstream Application of Botulinum Neurotoxins
1.3.1 Medical Uses
1.3.2 Cosmetics
1.4 Development History of Botulinum Neurotoxins
1.5 Market Status and Trend of Botulinum Neurotoxins 2013-2023
1.5.1 Global Botulinum Neurotoxins Market Status and Trend 2013-2023
1.5.2 Regional Botulinum Neurotoxins Market Status and Trend 2013-2023
CHAPTER 2 GLOBAL MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Development of Botulinum Neurotoxins 2013-2017
2.2 Production Market of Botulinum Neurotoxins by Regions
2.2.1 Production Volume of Botulinum Neurotoxins by Regions
2.2.2 Production Value of Botulinum Neurotoxins by Regions
2.3 Demand Market of Botulinum Neurotoxins by Regions
2.4 Production and Demand Status of Botulinum Neurotoxins by Regions
2.4.1 Production and Demand Status of Botulinum Neurotoxins by Regions 2013-2017
2.4.2 Import and Export Status of Botulinum Neurotoxins by Regions 2013-2017
CHAPTER 3 GLOBAL MARKET STATUS AND FORECAST BY TYPES
3.1 Production Volume of Botulinum Neurotoxins by Types
3.2 Production Value of Botulinum Neurotoxins by Types
3.3 Market Forecast of Botulinum Neurotoxins by Types
CHAPTER 4 GLOBAL MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Demand Volume of Botulinum Neurotoxins by Downstream Industry
4.2 Market Forecast of Botulinum Neurotoxins by Downstream Industry
CHAPTER 5 MARKET DRIVING FACTOR ANALYSIS OF BOTULINUM NEUROTOXINS
5.1 Global Economy Situation and Trend Overview
5.2 Botulinum Neurotoxins Downstream Industry Situation and Trend Overview
CHAPTER 6 BOTULINUM NEUROTOXINS MARKET COMPETITION STATUS BY MAJOR MANUFACTURERS
6.1 Production Volume of Botulinum Neurotoxins by Major Manufacturers
6.2 Production Value of Botulinum Neurotoxins by Major Manufacturers
6.3 Basic Information of Botulinum Neurotoxins by Major Manufacturers
6.3.1 Headquarters Location and Established Time of Botulinum Neurotoxins Major Manufacturer
6.3.2 Employees and Revenue Level of Botulinum Neurotoxins Major Manufacturer
6.4 Market Competition News and Trend
6.4.1 Merger, Consolidation or Acquisition News
6.4.2 Investment or Disinvestment News
6.4.3 New Product Development and Launch
CHAPTER 7 BOTULINUM NEUROTOXINS MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
7.1 Johnson & Johnson
7.1.1 Company profile
7.1.2 Representative Botulinum Neurotoxins Product
7.1.3 Botulinum Neurotoxins Sales, Revenue, Price and Gross Margin of Johnson & Johnson
7.2 GSK
7.2.1 Company profile
7.2.2 Representative Botulinum Neurotoxins Product
7.2.3 Botulinum Neurotoxins Sales, Revenue, Price and Gross Margin of GSK
7.3 Allergan
7.3.1 Company profile
7.3.2 Representative Botulinum Neurotoxins Product
7.3.3 Botulinum Neurotoxins Sales, Revenue, Price and Gross Margin of Allergan
7.4 Chong Kun Dang
7.4.1 Company profile
7.4.2 Representative Botulinum Neurotoxins Product
7.4.3 Botulinum Neurotoxins Sales, Revenue, Price and Gross Margin of Chong Kun Dang
7.5 Eisai
7.5.1 Company profile
7.5.2 Representative Botulinum Neurotoxins Product
7.5.3 Botulinum Neurotoxins Sales, Revenue, Price and Gross Margin of Eisai
7.6 Nestle
7.6.1 Company profile
7.6.2 Representative Botulinum Neurotoxins Product
7.6.3 Botulinum Neurotoxins Sales, Revenue, Price and Gross Margin of Nestle
7.7 Galderma
7.7.1 Company profile
7.7.2 Representative Botulinum Neurotoxins Product
7.7.3 Botulinum Neurotoxins Sales, Revenue, Price and Gross Margin of Galderma
7.8 Ipsen
7.8.1 Company profile
7.8.2 Representative Botulinum Neurotoxins Product
7.8.3 Botulinum Neurotoxins Sales, Revenue, Price and Gross Margin of Ipsen
7.9 Hugel
7.9.1 Company profile
7.9.2 Representative Botulinum Neurotoxins Product
7.9.3 Botulinum Neurotoxins Sales, Revenue, Price and Gross Margin of Hugel
7.10 Mentor
7.10.1 Company profile
7.10.2 Representative Botulinum Neurotoxins Product
7.10.3 Botulinum Neurotoxins Sales, Revenue, Price and Gross Margin of Mentor
7.11 CROMA
7.11.1 Company profile
7.11.2 Representative Botulinum Neurotoxins Product
7.11.3 Botulinum Neurotoxins Sales, Revenue, Price and Gross Margin of CROMA
7.12 Alphaeon
7.12.1 Company profile
7.12.2 Representative Botulinum Neurotoxins Product
7.12.3 Botulinum Neurotoxins Sales, Revenue, Price and Gross Margin of Alphaeon
7.13 OBI Pharma
7.13.1 Company profile
7.13.2 Representative Botulinum Neurotoxins Product
7.13.3 Botulinum Neurotoxins Sales, Revenue, Price and Gross Margin of OBI Pharma
7.14 Revance Therapeutics
7.14.1 Company profile
7.14.2 Representative Botulinum Neurotoxins Product
7.14.3 Botulinum Neurotoxins Sales, Revenue, Price and Gross Margin of Revance Therapeutics
7.15 Daewoong Pharmaceutical
7.15.1 Company profile
7.15.2 Representative Botulinum Neurotoxins Product
7.15.3 Botulinum Neurotoxins Sales, Revenue, Price and Gross Margin of Daewoong Pharmaceutical
7.16 Medy-Tox
7.17 EpiVax
7.18 Anterios
7.19 Escape Therapeutics
7.20 Lipella
7.21 Malvern Cosmeceutics
7.22 PharmaVital
7.23 Merz Pharma
7.24 Transdermal
7.25 Valeant Pharmaceuticals
7.26 CNBG
CHAPTER 8 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF BOTULINUM NEUROTOXINS
8.1 Industry Chain of Botulinum Neurotoxins
8.2 Upstream Market and Representative Companies Analysis
8.3 Downstream Market and Representative Companies Analysis
CHAPTER 9 COST AND GROSS MARGIN ANALYSIS OF BOTULINUM NEUROTOXINS
9.1 Cost Structure Analysis of Botulinum Neurotoxins
9.2 Raw Materials Cost Analysis of Botulinum Neurotoxins
9.3 Labor Cost Analysis of Botulinum Neurotoxins
9.4 Manufacturing Expenses Analysis of Botulinum Neurotoxins
CHAPTER 10 MARKETING STATUS ANALYSIS OF BOTULINUM NEUROTOXINS
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
CHAPTER 11 REPORT CONCLUSION
CHAPTER 12 RESEARCH METHODOLOGY AND REFERENCE
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Reference
1.1 Definition of Botulinum Neurotoxins in This Report
1.2 Commercial Types of Botulinum Neurotoxins
1.2.1 Botulinum Neurotoxins A (BoNT/A)
1.2.2 Botulinum Neurotoxins B (BoNT/B)
1.2.3 Botulinum Neurotoxins E (BoNT/E)
1.2.4 Botulinum Neurotoxins F (BoNT/F)
1.2.5 Botulinum Neurotoxins C (BoNT/C)
1.2.6 Botulinum Neurotoxins D (BoNT/D)
1.2.7 Botulinum Neurotoxins G (BoNT/G)
1.3 Downstream Application of Botulinum Neurotoxins
1.3.1 Medical Uses
1.3.2 Cosmetics
1.4 Development History of Botulinum Neurotoxins
1.5 Market Status and Trend of Botulinum Neurotoxins 2013-2023
1.5.1 Global Botulinum Neurotoxins Market Status and Trend 2013-2023
1.5.2 Regional Botulinum Neurotoxins Market Status and Trend 2013-2023
CHAPTER 2 GLOBAL MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Development of Botulinum Neurotoxins 2013-2017
2.2 Production Market of Botulinum Neurotoxins by Regions
2.2.1 Production Volume of Botulinum Neurotoxins by Regions
2.2.2 Production Value of Botulinum Neurotoxins by Regions
2.3 Demand Market of Botulinum Neurotoxins by Regions
2.4 Production and Demand Status of Botulinum Neurotoxins by Regions
2.4.1 Production and Demand Status of Botulinum Neurotoxins by Regions 2013-2017
2.4.2 Import and Export Status of Botulinum Neurotoxins by Regions 2013-2017
CHAPTER 3 GLOBAL MARKET STATUS AND FORECAST BY TYPES
3.1 Production Volume of Botulinum Neurotoxins by Types
3.2 Production Value of Botulinum Neurotoxins by Types
3.3 Market Forecast of Botulinum Neurotoxins by Types
CHAPTER 4 GLOBAL MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Demand Volume of Botulinum Neurotoxins by Downstream Industry
4.2 Market Forecast of Botulinum Neurotoxins by Downstream Industry
CHAPTER 5 MARKET DRIVING FACTOR ANALYSIS OF BOTULINUM NEUROTOXINS
5.1 Global Economy Situation and Trend Overview
5.2 Botulinum Neurotoxins Downstream Industry Situation and Trend Overview
CHAPTER 6 BOTULINUM NEUROTOXINS MARKET COMPETITION STATUS BY MAJOR MANUFACTURERS
6.1 Production Volume of Botulinum Neurotoxins by Major Manufacturers
6.2 Production Value of Botulinum Neurotoxins by Major Manufacturers
6.3 Basic Information of Botulinum Neurotoxins by Major Manufacturers
6.3.1 Headquarters Location and Established Time of Botulinum Neurotoxins Major Manufacturer
6.3.2 Employees and Revenue Level of Botulinum Neurotoxins Major Manufacturer
6.4 Market Competition News and Trend
6.4.1 Merger, Consolidation or Acquisition News
6.4.2 Investment or Disinvestment News
6.4.3 New Product Development and Launch
CHAPTER 7 BOTULINUM NEUROTOXINS MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
7.1 Johnson & Johnson
7.1.1 Company profile
7.1.2 Representative Botulinum Neurotoxins Product
7.1.3 Botulinum Neurotoxins Sales, Revenue, Price and Gross Margin of Johnson & Johnson
7.2 GSK
7.2.1 Company profile
7.2.2 Representative Botulinum Neurotoxins Product
7.2.3 Botulinum Neurotoxins Sales, Revenue, Price and Gross Margin of GSK
7.3 Allergan
7.3.1 Company profile
7.3.2 Representative Botulinum Neurotoxins Product
7.3.3 Botulinum Neurotoxins Sales, Revenue, Price and Gross Margin of Allergan
7.4 Chong Kun Dang
7.4.1 Company profile
7.4.2 Representative Botulinum Neurotoxins Product
7.4.3 Botulinum Neurotoxins Sales, Revenue, Price and Gross Margin of Chong Kun Dang
7.5 Eisai
7.5.1 Company profile
7.5.2 Representative Botulinum Neurotoxins Product
7.5.3 Botulinum Neurotoxins Sales, Revenue, Price and Gross Margin of Eisai
7.6 Nestle
7.6.1 Company profile
7.6.2 Representative Botulinum Neurotoxins Product
7.6.3 Botulinum Neurotoxins Sales, Revenue, Price and Gross Margin of Nestle
7.7 Galderma
7.7.1 Company profile
7.7.2 Representative Botulinum Neurotoxins Product
7.7.3 Botulinum Neurotoxins Sales, Revenue, Price and Gross Margin of Galderma
7.8 Ipsen
7.8.1 Company profile
7.8.2 Representative Botulinum Neurotoxins Product
7.8.3 Botulinum Neurotoxins Sales, Revenue, Price and Gross Margin of Ipsen
7.9 Hugel
7.9.1 Company profile
7.9.2 Representative Botulinum Neurotoxins Product
7.9.3 Botulinum Neurotoxins Sales, Revenue, Price and Gross Margin of Hugel
7.10 Mentor
7.10.1 Company profile
7.10.2 Representative Botulinum Neurotoxins Product
7.10.3 Botulinum Neurotoxins Sales, Revenue, Price and Gross Margin of Mentor
7.11 CROMA
7.11.1 Company profile
7.11.2 Representative Botulinum Neurotoxins Product
7.11.3 Botulinum Neurotoxins Sales, Revenue, Price and Gross Margin of CROMA
7.12 Alphaeon
7.12.1 Company profile
7.12.2 Representative Botulinum Neurotoxins Product
7.12.3 Botulinum Neurotoxins Sales, Revenue, Price and Gross Margin of Alphaeon
7.13 OBI Pharma
7.13.1 Company profile
7.13.2 Representative Botulinum Neurotoxins Product
7.13.3 Botulinum Neurotoxins Sales, Revenue, Price and Gross Margin of OBI Pharma
7.14 Revance Therapeutics
7.14.1 Company profile
7.14.2 Representative Botulinum Neurotoxins Product
7.14.3 Botulinum Neurotoxins Sales, Revenue, Price and Gross Margin of Revance Therapeutics
7.15 Daewoong Pharmaceutical
7.15.1 Company profile
7.15.2 Representative Botulinum Neurotoxins Product
7.15.3 Botulinum Neurotoxins Sales, Revenue, Price and Gross Margin of Daewoong Pharmaceutical
7.16 Medy-Tox
7.17 EpiVax
7.18 Anterios
7.19 Escape Therapeutics
7.20 Lipella
7.21 Malvern Cosmeceutics
7.22 PharmaVital
7.23 Merz Pharma
7.24 Transdermal
7.25 Valeant Pharmaceuticals
7.26 CNBG
CHAPTER 8 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF BOTULINUM NEUROTOXINS
8.1 Industry Chain of Botulinum Neurotoxins
8.2 Upstream Market and Representative Companies Analysis
8.3 Downstream Market and Representative Companies Analysis
CHAPTER 9 COST AND GROSS MARGIN ANALYSIS OF BOTULINUM NEUROTOXINS
9.1 Cost Structure Analysis of Botulinum Neurotoxins
9.2 Raw Materials Cost Analysis of Botulinum Neurotoxins
9.3 Labor Cost Analysis of Botulinum Neurotoxins
9.4 Manufacturing Expenses Analysis of Botulinum Neurotoxins
CHAPTER 10 MARKETING STATUS ANALYSIS OF BOTULINUM NEUROTOXINS
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
CHAPTER 11 REPORT CONCLUSION
CHAPTER 12 RESEARCH METHODOLOGY AND REFERENCE
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Reference
